News on PRR
"Cancer therapy minnow Prima BioMed is set to announce as early as today that it has secured $25.5 million through a convertible note facility provided by United States small-cap fund manager SpringTree Capital."
- Forums
- ASX - Day Trading
- daytrade diaries... july 20
News on PRR"Cancer therapy minnow Prima BioMed is set to...
Featured News
Featured News
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online